← back

The whale feed

Who just crossed 5%?

When anyone — family offices, activist funds, sovereign wealth, famous CEOs buying into other companies — crosses a 3–5% voting- rights threshold in an EU or UK listed company, they must disclose it within 2–4 trading days. A different signal from Article 19 PDMR filings — conviction across the table, not inside one.

Filtered byFaron Pharmaceuticals Oy×Clear all
Buy Faron Pharmaceuticals Oy
Pick a broker. We handle the signal, they handle execution.

Affiliate links — we may earn a referral fee if you sign up.

Matching filings

Showing 22 most recent
FiledFilerCompanyMoveNew %Source
2026-06-22
3w ago
🇫🇮Unnamed Filer (Faron Pharmaceuticals Oy)Faron Pharmaceuticals Oydisclosedregulator →
2026-06-17
4w ago
🇫🇮Unnamed Filer (Faron Pharmaceuticals Oy)Faron Pharmaceuticals Oydisclosedregulator →
2026-06-17
4w ago
🇫🇮Unnamed Filer (Faron Pharmaceuticals Oy)Faron Pharmaceuticals Oydisclosedregulator →
2026-06-15
1mo ago
🇫🇮Unnamed Filer (Faron Pharmaceuticals Oy)Faron Pharmaceuticals Oydisclosedregulator →
2026-06-11
1mo ago
🇫🇮Unnamed Filer (Faron Pharmaceuticals Oy)Faron Pharmaceuticals Oydisclosedregulator →
2026-06-10
1mo ago
🇫🇮Unnamed Filer (Faron Pharmaceuticals Oy)Faron Pharmaceuticals Oydisclosedregulator →
2026-06-08
1mo ago
🇫🇮Unnamed Filer (Faron Pharmaceuticals Oy)Faron Pharmaceuticals Oydisclosedregulator →
2026-06-04
1mo ago
🇫🇮Unnamed Filer (Faron Pharmaceuticals Oy)Faron Pharmaceuticals Oydisclosedregulator →
2026-06-01
1mo ago
🇫🇮Unnamed Filer (Faron Pharmaceuticals Oy)Faron Pharmaceuticals Oydisclosedregulator →
2026-05-28
1mo ago
🇫🇮Unnamed Filer (Faron Pharmaceuticals Oy)Faron Pharmaceuticals Oydisclosedregulator →
2026-05-18
1mo ago
🇫🇮Unnamed Filer (Faron Pharmaceuticals Oy)Faron Pharmaceuticals Oydisclosedregulator →
2026-05-05
2mo ago
🇫🇮Unnamed Filer (Faron Pharmaceuticals Oy)Faron Pharmaceuticals Oydisclosedregulator →
2026-04-22
2mo ago
🇫🇮Unnamed Filer (Faron Pharmaceuticals Oy)Faron Pharmaceuticals Oydisclosedregulator →
2026-04-20
2mo ago
🇫🇮Unnamed Filer (Faron Pharmaceuticals Oy)Faron Pharmaceuticals Oydisclosedregulator →
2026-04-20
2mo ago
🇫🇮Unnamed Filer (Faron Pharmaceuticals Oy)Faron Pharmaceuticals Oydisclosedregulator →
2026-04-16
3mo ago
🇫🇮Unnamed Filer (Faron Pharmaceuticals Oy)Faron Pharmaceuticals Oydisclosedregulator →
2026-03-24
3mo ago
🇫🇮Unnamed Filer (Faron Pharmaceuticals Oy)Faron Pharmaceuticals Oydisclosedregulator →
2026-03-12
4mo ago
🇫🇮Unnamed Filer (Faron Pharmaceuticals Oy)Faron Pharmaceuticals Oydisclosedregulator →
2026-03-11
4mo ago
🇫🇮Unnamed Filer (Faron Pharmaceuticals Oy)Faron Pharmaceuticals Oydisclosedregulator →
2025-12-04
7mo ago
🇫🇮Unnamed Filer (Faron Pharmaceuticals Oy)Faron Pharmaceuticals Oydisclosedregulator →
2025-10-21
8mo ago
🇫🇮Unnamed Filer (Faron Pharmaceuticals Oy)Faron Pharmaceuticals Oydisclosedregulator →
2025-08-08
11mo ago
🇫🇮Unnamed Filer (Faron Pharmaceuticals Oy)Faron Pharmaceuticals Oydisclosedregulator →

Why this signal matters

A CEO buying €1m of their own stock is confidence. A family office quietly accumulating 5% of a small listed industrial is conviction across the table — and often a leading indicator of an activist campaign, a take-private bid, a sovereign wealth allocation, or a cornerstone investment. Academic literature (Brav, Jiang, Kim 2010 on activism; Bebchuk et al 2013) consistently finds substantial outperformance in the months following 13D / equivalent filings in the US. Europe's Transparency Directive is the European equivalent.